NORGES BANK, a registered investment adviser, initiated a new position in Merck & Co., Inc. (NYSE:MRK) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 37,981,502 shares of the Healthcare company, valued at approximately $4.0B as of the filing date.
Merck & Co., Inc.'s stock currently trades at $117.00 with a market capitalization of $248.8B.
